{"id":40609,"date":"2013-10-07T13:51:58","date_gmt":"2013-10-07T17:51:58","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=40609"},"modified":"2013-10-07T13:56:00","modified_gmt":"2013-10-07T17:56:00","slug":"a-heady-collection","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2013\/10\/07\/a-heady-collection\/","title":{"rendered":"a heady collection&#8230;"},"content":{"rendered":"\n<p align=\"justify\">This is a reposting from August [<a href=\"http:\/\/1boringoldman.com\/index.php\/2013\/08\/22\/a-little-light-reading\/\" target=\"_blank\">a little light reading&hellip;<\/a>]. Today, Ed Silverman of Pharmalot has an interview with <strong><font color=\"#200020\">Marc Rodwin<\/font><\/strong>, the Safra Fellow who put this collection together [see <a href=\"http:\/\/www.pharmalive.com\/corruption-hurts-patient-care-medical-knowledge-rodwin-explains\" target=\"_blank\">Pharma Corruption Hurts Patient Care &amp; Medical Knowledge: Rodwin Explains<\/a>]. It&#8217;s a good interview and a heady collection, but well worth the investment&#8230;  <\/p>\n<table width=\"95%\" cellspacing=\"0\" cellpadding=\"4\" border=\"0\" align=\"center\">\n<tr>\n<td>\n<div align=\"center\"><a href=\"http:\/\/www.ethics.harvard.edu\/lab\/featured\/325-jlme-symposium\" target=\"_blank\">Institutional Corruption and Pharmaceutical Policy<\/a><br \/>         <strong><font color=\"#200020\">An Edmond J. Safra Center Symposium&nbsp;<\/font><\/strong><br \/>         <strong><font color=\"#200020\">Harvard University<\/font><\/strong><br \/>         <strong><font color=\"#200020\">Journal of Law, Medicine and Ethics <\/font><\/strong><br \/>         Vol. 14, No. 3 (2013)<\/div>\n<div><sup>   <\/p>\n<ul>\n<li>\n<div align=\"justify\">Marc Rodwin, <em><a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2298140\">Institutional Corruption and Pharmaceutical Policy<\/a><\/em><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Lawrence Lessig, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2295067\"><em>Foreword: &lsquo;Institutional Corruption&rsquo; Defined<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Gregg Fields, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2293620\"><em>Parallel Problems: Applying Institutional Corruption Analysis of Congress to Big Pharma<br \/>         <\/em><\/a><\/div>\n<\/li>\n<\/ul>\n<div align=\"justify\"><strong><font color=\"#200020\">1. SYSTEMIC PROBLEMS<\/font><\/strong><\/div>\n<ul>\n<li>\n<div align=\"justify\">Paul D. Jorgensen, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2292148\"><em>Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Marc-Andr\u00e9 Gagnon, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2286415\"><em>Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Marc A. Rodwin, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2295002\"><em>Five Un-Easy Pieces of Pharmaceutical Policy Reform<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Donald W. Light, Joel Lexchin, Jonathan J. Darrow, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2282014\"><em>Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Jennifer E. Miller, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2293629\"><em>From  Bad Pharma to Good Pharma: Aligning Market Forces with Good and  Trustworthy Practices Through Accreditation, Certification, and Rating<\/em><\/a><\/div>\n<\/li>\n<\/ul>\n<div align=\"justify\"><strong><font color=\"#200020\">2. MEDICAL RESEARCH<\/font><\/strong><\/div>\n<ul>\n<li>\n<div align=\"justify\">Abigail B. Brown, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2286446\"><em>Understanding Pharmaceutical Research Manipulation in the Context of Accounting Manipulation<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Yuval Feldman, Rebecca L. Gauthier, and Troy H. Schuler, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2269461\"><em>Curbing Misconduct in the Pharmaceutical Industry: Insights from Behavioral Ethics and the Behavioral Approach to Law<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Garry C. Gray, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2294620\"><em>The Ethics of Pharmaceutical Research Funding: A Social Organization Approach<\/em><\/a><\/div>\n<\/li>\n<\/ul>\n<div align=\"justify\"><strong><font color=\"#200020\">3. MEDICAL KNOWLEDGE AND PRACTICE<\/font><\/strong><\/div>\n<ul>\n<li>\n<div align=\"justify\">Sergio Sismondo, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2272672\"><em>Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won&rsquo;t Cast Light On<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Lisa Cosgrove and Emily E. Wheeler, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2286724\"><em>Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines<\/em> <\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Marc A. Rodwin, <a target=\"_blank\" href=\"http:\/\/papers.ssrn.com\/abstract=2292037\"><em>Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use<\/em><\/a><\/div>\n<\/li>\n<\/ul>\n<div align=\"justify\"><strong><font color=\"#200020\">4. MARKETING<\/font><\/strong><\/div>\n<ul>\n<li>\n<div align=\"justify\">Sunita Sah and Adriane Fugh-Berman,<a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2286433\"><em> Physicians Under the Influence: Social Psychology and Industry Marketing Strategies<\/em><\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\">Amy Snow Landa and Carl Elliott, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2297102\"><em>From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians<\/em><\/a><\/div>\n<\/li>\n<\/ul>\n<div align=\"justify\"><strong><font color=\"#200020\">5. PATIENT ADVOCATES<\/font><\/strong><\/div>\n<ul>\n<li>\n<div align=\"justify\">Susannah L. Rose, <a target=\"_blank\" href=\"http:\/\/ssrn.com\/abstract=2295485\"><em>Patient Advocacy Organizations: Institutional Conflicts of Interest, Trust, and Trustworthiness<\/em><\/a><\/div>\n<\/li>\n<\/ul>\n<p>  <\/sup><\/div>\n<\/td>\n<\/tr>\n<\/table>\n<p align=\"right\"><sup><strong><font color=\"#200020\">hat tip to Ben Goldacre on Twitter <\/font><\/strong>&nbsp;&nbsp;<img decoding=\"async\" border=\"0\" align=\"absmiddle\" height=\"35\" src=\"http:\/\/1boringoldman.com\/images\/hat-tip.gif\" \/><\/sup><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is a reposting from August [a little light reading&hellip;]. Today, Ed Silverman of Pharmalot has an interview with Marc Rodwin, the Safra Fellow who put this collection together [see Pharma Corruption Hurts Patient Care &amp; Medical Knowledge: Rodwin Explains]. It&#8217;s a good interview and a heady collection, but well worth the investment&#8230; Institutional Corruption [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-40609","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/40609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=40609"}],"version-history":[{"count":3,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/40609\/revisions"}],"predecessor-version":[{"id":40612,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/40609\/revisions\/40612"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=40609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=40609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=40609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}